Last updated: March 7, 2024
Sponsor: King's College Hospital NHS Trust
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hyponatremia
Treatment
Tolvaptan
Clinical Study ID
NCT06171100
GafREC: Endo205
Ages 18-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients presenting to Accident & Emergency department or seen as inpatients withmoderate to severe hyponatraemia (sNa: <125mmol) associated with SIADH and notresponding to conservative measures of hyponatraemia management.
- Patients of all genders aged 18-90 y.o
Exclusion
Exclusion Criteria:
- Pregnant women and patients aged < 18y.o
- Hyponatraemia not associated with SIADH
Study Design
Total Participants: 180
Treatment Group(s): 1
Primary Treatment: Tolvaptan
Phase:
Study Start date:
March 15, 2024
Estimated Completion Date:
December 30, 2024
Connect with a study center
King's College Hospital NHS Foundation Trust
London,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.